ATTN:Denise/Merck PD-1 FDA approval 2015
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

ATTN:Denise/Merck PD-1 FDA approval 2015

› Forums › Cutaneous Melanoma Community › ATTN:Denise/Merck PD-1 FDA approval 2015

  • This topic is empty.
  • Post
    • November 7, 2013 at 3:58 pm
    killmel
    Participant

      Hi

      I have read many post from people wondering when Merck PD1 will get FDA approval. Sadly, it seems like a long time to wait till 2015.

      In this article Merck is stating the following:

      "Merck said Sunday it plans to start late-stage clinical trials testing lambrolizumab in patients with a deadly form of skin cancer, melanoma, as well as non-small-cell lung cancer, in the third quarter. If all goes well, the company could file for regulatory approval in 2015."

      http://www.marketwatch.com/story/merck-drug-shrinks-tumors-in-melanoma-patients-2013-06-02

      Denise, I know that you need this drug NOW! I would contact BMS & Merck.

      I read in this article and other articles the names of some key Merck personnel working with the PD1 trial so maybe you can contact them for compassionate use.

      I would mention in your email that you are aware of Nick Auden's petition requesting PD1 compassionate use and you want the SAME consideration for PD1 under compassionate use. I would also get your Doctors to support your request that you can benefit from PD1.

      I am NOT sure that these are valid emails but you can try them.Here is the contact information that I found for these key Merck personnel working with the PD1 trial:

      Merck Research Doctor-Dr. Scot Ebbinghaus    email:[email protected]

      Merck VP-Gary Gilliland  email: [email protected]

      address:

      Roger Perlmutter-President

      Merck Research Laboratories
      126 East Lincoln Ave
      Rahway, NJ 07065-0900

       

      Here is the contact for BMS:

      Dr. Michael Giordano – [email protected]

       Les Enterline: [email protected]

      [email protected]

       

      Good Luck

    Tagged: 

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.